BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37574401)

  • 1. Influence of weight variation on long-term mortality of patients with heart failure.
    Melo N; Ferreira AI; Silva C; Oliveira D; Enes J; Lume MJ; Pereira J; Araújo JP; Lourenço P
    Arch Cardiovasc Dis; 2023; 116(8-9):403-410. PubMed ID: 37574401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Heart Failure Overweight/Obesity Survival Paradox: The Missing Sex Link.
    Vest AR; Wu Y; Hachamovitch R; Young JB; Cho L
    JACC Heart Fail; 2015 Nov; 3(11):917-26. PubMed ID: 26454846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.
    Kido K; Bianco C; Caccamo M; Fang W; Sokos G
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):619-624. PubMed ID: 34138675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss in Obese Patients With Heart Failure.
    Zamora E; Díez-López C; Lupón J; de Antonio M; Domingo M; Santesmases J; Troya MI; Díez-Quevedo C; Altimir S; Bayes-Genis A
    J Am Heart Assoc; 2016 Mar; 5(3):e002468. PubMed ID: 27013541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain.
    Blomstrand P; Sjöblom P; Nilsson M; Wijkman M; Engvall M; Länne T; Nyström FH; Östgren CJ; Engvall J
    Cardiovasc Diabetol; 2018 Aug; 17(1):113. PubMed ID: 30107798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study.
    Kamisaka K; Kamiya K; Iwatsu K; Iritani N; Imoto S; Adachi T; Iida Y; Yamada S;
    ESC Heart Fail; 2021 Dec; 8(6):5293-5303. PubMed ID: 34599855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High percent body fat mass predicts lower risk of cardiac events in patients with heart failure: an explanation of the obesity paradox.
    Ohori K; Yano T; Katano S; Kouzu H; Honma S; Shimomura K; Inoue T; Takamura Y; Nagaoka R; Koyama M; Nagano N; Fujito T; Nishikawa R; Ishigo T; Watanabe A; Hashimoto A; Miura T
    BMC Geriatr; 2021 Jan; 21(1):16. PubMed ID: 33407196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction.
    Gentile F; Sciarrone P; Zamora E; De Antonio M; Santiago E; Domingo M; Aimo A; Giannoni A; Passino C; Codina P; Bayes-Genis A; Lupon J; Emdin M; Vergaro G
    Eur J Prev Cardiol; 2021 Aug; 28(9):948-955. PubMed ID: 34402870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI, Infarct Size, and Clinical Outcomes Following Primary PCI: Patient-Level Analysis From 6 Randomized Trials.
    Shahim B; Redfors B; Chen S; Thiele H; Eitel I; Gkargkoulas F; Crowley A; Ben-Yehuda O; Maehara A; Stone GW
    JACC Cardiovasc Interv; 2020 Apr; 13(8):965-972. PubMed ID: 32327093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sex and myocardial function on association of obesity with mortality in Asian patients with acute heart failure: a retrospective analysis from the STRATS-AHF registry.
    Park CS; Park JB; Park JJ; Park JH; Cho GY
    BMJ Open; 2020 Feb; 10(2):e031608. PubMed ID: 32047009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction.
    Nishi I; Seo Y; Hamada-Harimura Y; Yamamoto M; Ishizu T; Sugano A; Sato K; Sai S; Obara K; Suzuki S; Koike A; Aonuma K; Ieda M;
    ESC Heart Fail; 2019 Apr; 6(2):396-405. PubMed ID: 30706996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failure.
    Täger T; Franke J; Frey N; Frankenstein L; Fröhlich H
    Nutr Metab Cardiovasc Dis; 2023 Feb; 33(2):416-423. PubMed ID: 36604261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Paradox in Heart Failure Revisited: Etiology as Effect Modifier.
    Huang L; Zhao X; Liang L; Tian P; Chen Y; Zhai M; Huang Y; Zhou Q; Zhang Y; Zhang J
    Am J Cardiol; 2023 Nov; 207():294-301. PubMed ID: 37769574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No benefit from the obesity paradox for diabetic patients with heart failure.
    Zamora E; Lupón J; Enjuanes C; Pascual-Figal D; de Antonio M; Domingo M; Comín-Colet J; Vila J; Peñafiel J; Farré N; Alonso N; Santesmases J; Troya M; Bayés-Genís A
    Eur J Heart Fail; 2016 Jul; 18(7):851-8. PubMed ID: 27312985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.
    Khalid U; Ather S; Bavishi C; Chan W; Loehr LR; Wruck LM; Rosamond WD; Chang PP; Coresh J; Virani SS; Nambi V; Bozkurt B; Ballantyne CM; Deswal A
    J Am Coll Cardiol; 2014 Dec; 64(25):2743-9. PubMed ID: 25541126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underweight Is Associated with Poor Prognosis in Heart Failure with Preserved Ejection Fraction.
    Matsuhiro Y; Nishino M; Ukita K; Kawamura A; Nakamura H; Yasumoto K; Tsuda M; Okamoto N; Tanaka A; Matsunaga-Lee Y; Yano M; Egami Y; Shutta R; Tanouchi J; Yamada T; Yasumura Y; Tamaki S; Hayashi T; Nakagawa A; Nakagawa Y; Sotomi Y; Nakatani D; Hikoso S; Sakata Y;
    Int Heart J; 2021 Sep; 62(5):1042-1051. PubMed ID: 34544985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index Categories.
    Vergaro G; Gentile F; Meems LMG; Aimo A; Januzzi JL; Richards AM; Lam CSP; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; de Boer RA; Emdin M
    JACC Heart Fail; 2021 Sep; 9(9):653-663. PubMed ID: 34246607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.
    Pocock SJ; McMurray JJ; Dobson J; Yusuf S; Granger CB; Michelson EL; Ostergren J; Pfeffer MA; Solomon SD; Anker SD; Swedberg KB
    Eur Heart J; 2008 Nov; 29(21):2641-50. PubMed ID: 18819960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Obesity Paradox in Patients with Significant Tricuspid Regurgitation: Effects of Obesity on Right Ventricular Remodeling and Long-Term Prognosis.
    Dietz MF; Prihadi EA; van der Bijl P; Ajmone Marsan N; Bax JJ; Delgado V
    J Am Soc Echocardiogr; 2021 Jan; 34(1):20-29. PubMed ID: 32921538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of weight loss and physical activity on all-cause mortality of overweight men and women.
    Østergaard JN; Grønbaek M; Schnohr P; Sørensen TI; Heitmann BL
    Int J Obes (Lond); 2010 Apr; 34(4):760-9. PubMed ID: 20065967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.